RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II) — Yoshinobu Onuma (2016) | RDL Network
RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II)
Journal of the American College of Cardiology 67(13): 425-425
Yuki Katagiri, Yoshinobu Onuma, Taku Asano, Ply Chichareon, Carlos Collet, Yosuke Miyazaki, Jan J. Piek, Joanna J. Wykrzykowska, Alexandre Abizaid, John A. Ormiston, Bernard Chevalier, Patrick W. Serruys
Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, Pannipa Suwannasom, Maik J. Grundeken, Héctor M. García‐García, Antonio L. Bartorelli, Robert Whitbourn, Bernard Chevalier, Alexandre Abizaid, John A. Ormiston, Richard Rapoza, Susan Veldhof, Yoshinobu Onuma, Patrick W. Serruys
Takashi Muramatsu, Yoshinobu Onuma, Robert J. Van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof, Wai‐Fung Cheong, Robert Whitbourn, Antonio L. Bartorelli, Alexandre Abizaid, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.